Mostrando 3 resultados de: 3
Filtros aplicados
Origen
scopus(3)
Alpha-secretase ADAM10 regulation: Insights into Alzheimer’s disease treatment
ReviewAbstract: ADAM (a disintegrin and metalloproteinase) is a family of widely expressed, transmembrane and secretPalabras claves:ADAM10, Alzheimer’s disease, regulation, TreatmentAutores:Antoni Camins, Cominetti M.R., Manzine P.R., Peron R., Vatanabe I.P.Fuentes:scopusMetformin a potential pharmacological strategy in late onset Alzheimer’s disease treatment
ReviewAbstract: Alzheimer’s disease (AD) is one of the most devastating brain disorders. Currently, there are no effPalabras claves:Alzheimer’s disease, AMP activated protein kinase AMPK, Beta amyloid, diabetes mellitus, Insulin Resistance, Metformin, Tau protein hyperphosphorylationAutores:Antoni Camins, Cano A., Ettcheto M., Javan M., Manzine P.R., Olloquequi J., Poor S.R., Sanchez-Lopez E.Fuentes:scopusTriple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
ArticleAbstract:Palabras claves:Alzheimer’s disease, glucagon, glucagon-like peptide, glucose-dependent insulinotropic peptide, Type 2 DiabetesAutores:Antoni Camins, Auladell C., Bulló M., Busquets O., Castro-Torres R.D., Ettcheto M., Folch J., Manzine P.R., Olloquequi J., Sureda F.X., Verdaguer E., Zárate C.B.Fuentes:scopus